B192990

Language code

eng

Shelfmark

14.6 TAI

Main entry - corporate name

Tainted Blood

Title

Tainted Blood: Stories behind the statistics

Publication, distribution, etc.

Tainted Blood, 2011

Physical description

51 pages, H 21 x W 21 cm

Biographical or historical data

The Infected Blood Inquiry was established to examine the circumstances in which patients treated by the NHS before 1996 received infected blood and blood products. The government’s decision to investigate what happened followed years of campaigning by those affected by the scandal. The inquiry, chaired by Sir Brian Langstaff and beginning on 2 July 2018, has published a total of three reports. Importantly, the Inquiry report found that the Government, civil service and NHS over the decades tried to cover up and deny any actions rather than working to support those affected. It also details that people who were affected faced a huge amount of stigma. The lack of understanding about how the viruses were transmitted meant that people lost jobs, friends and relationships.

In the 1970s, the UK was struggling to meet the demand for blood-clotting treatments; therefore, it looked to import supplies from the United States. Factor VIII was the imported US product, which was made by pooling plasma from tens of thousands of donors. However, much of the blood was brought from high-risk donors, and if just one was carrying a virus, the entire batch could be contaminated. More than 30,000 people in the UK were infected with HIV and hepatitis B and or hepatitis C. Two main groups of NHS patients were affected. One group was people with haemophilia and similar disorders who have a rare genetic condition that means their blood doesn’t clot properly. After being given the infected treatments, about 1250 people in the UK with bleeding disorders, including 380 children, developed both HIV and hepatitis C. A second group of patients was given blood transfusions after childbirth surgery or other medical treatment. This group was mainly infected with hepatitis C. In total, it’s believed that 2,900 people have died as a result of the Factor VIII product.

Subject

Blood (Categories)

001B192990

003UKLeTMM

00520260521145029.7

020##$a

0410#$aeng

096##$a14.6 TAI

1102#$aTainted Blood

24510$aTainted Blood: Stories behind the statistics

260##$bTainted Blood$c2011

300##$a51 pages$cH 21 x W 21 cm

336##$atext$btxt$2rdacontent

337##$aunmediated$bn$2rdamedia

338##Undefined$avolume$bnc$2rdacarrier

545##$aThe Infected Blood Inquiry was established to examine the circumstances in which patients treated by the NHS before 1996 received infected blood and blood products. The government’s decision to investigate what happened followed years of campaigning by those affected by the scandal. The inquiry, chaired by Sir Brian Langstaff and beginning on 2 July 2018, has published a total of three reports. Importantly, the Inquiry report found that the Government, civil service and NHS over the decades tried to cover up and deny any actions rather than working to support those affected. It also details that people who were affected faced a huge amount of stigma. The lack of understanding about how the viruses were transmitted meant that people lost jobs, friends and relationships. In the 1970s, the UK was struggling to meet the demand for blood-clotting treatments; therefore, it looked to import supplies from the United States. Factor VIII was the imported US product, which was made by pooling plasma from tens of thousands of donors. However, much of the blood was brought from high-risk donors, and if just one was carrying a virus, the entire batch could be contaminated. More than 30,000 people in the UK were infected with HIV and hepatitis B and or hepatitis C. Two main groups of NHS patients were affected. One group was people with haemophilia and similar disorders who have a rare genetic condition that means their blood doesn’t clot properly. After being given the infected treatments, about 1250 people in the UK with bleeding disorders, including 380 children, developed both HIV and hepatitis C. A second group of patients was given blood transfusions after childbirth surgery or other medical treatment. This group was mainly infected with hepatitis C. In total, it’s believed that 2,900 people have died as a result of the Factor VIII product.

650#0$aBlood

8528#$aLibrary